James Owain Jones, Rebecca Wray, Carla Castignani, Duncan McKenzie, Camilla Cucinotta, Gemma Tsang-Pells, Helen Su, Sarah Joanne Welsh, Axel Bex, Paul D. Nathan, David Harrison, Tim Eisen, Max Emmerich, Samra Turajlic, Elena Frangou, Angela Mary Meade, Thomas Powles, James M. G. Larkin, Adam Laing, Grant D. Stewart. "Peripheral blood correlates of outcomes with adjuvant tremelimumab plus durvalumab for patients with renal cell carcinoma at high or intermediate risk of relapse: Initial results from the TransRAMPART study.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.7_suppl.527